China’s Amended Patent Law Could Facilitate Compulsory Licenses Of Pharmaceuticals – Patent Attorneys
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Leaders of China's national legislature are currently reviewing amendments to the patent law that could make it easier to force global pharmaceutical firms to license drugs to Chinese competitors in the event of a public health crisis
You may also be interested in...
China Compulsory Licensing Reg Opens Door For Generics Of Patented Drugs
Taking the lead from India’s recent compulsory license for Bayer’s Nexavar, China passes a compulsory license regulation that could allow generics on patented drugs.
China Compulsory Licensing Reg Opens Door For Generics Of Patented Drugs
Taking the lead from India’s recent compulsory license for Bayer’s Nexavar, China passes a compulsory license regulation that could allow generics on patented drugs.
Thailand Could Seek WTO Solution On Compulsory Licensing, Generic Drugs
SHANGHAI - Multinational drug companies and authorities across developed countries have censured Thailand for using compulsory licensing - a method of forcing pharmaceutical outfits holding patents on innovative medicines to allow other companies to turn out the product